Parmax Pharma
₹31.71
-0.63 (-1.95%)
15 May, 2024 07:21 BSE: 540359
NSE: PARMAXISIN: INE240T01014
Start SIP in Parmax Pharma
Start SIPParmax Pharma Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Parmax Pharma Financials
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 1 | 4 | 1 | 6 |
| Operating Expenses Qtr Cr | 2 | 5 | 2 | 6 |
| Operating Profit Qtr Cr | -1 | -1 | -1 | 1 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | -2 | -1 | -1 | 0 |
Parmax Pharma Technicals
EMA & SMA
Current Price
₹31.71
-0.63 (-1.95%)
- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹30.87
- 50 Day
- ₹30.77
- 100 Day
- ₹30.94
- 200 Day
- ₹31.27
- 20 Day
- ₹30.66
- 50 Day
- ₹30.42
- 100 Day
- ₹31.38
- 200 Day
- ₹30.91
Parmax Pharma Resistance and Support
PIVOT
₹32.39
| Resistance | |
|---|---|
| First Resistance | 33.17 |
| Second Resistance | 34.58 |
| Third Resistance | 35.37 |
| RSI | 52.95 |
| MFI | 47.47 |
| MACD Single Line | 0.14 |
| MACD | 0.38 |
| Support | |
|---|---|
| First Resistance | 30.97 |
| Second Resistance | 30.18 |
| Third Resistance | 28.77 |
Parmax Pharma Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 3,056 | 272,198 | 89.07 |
| Week | 18,002 | 1,108,178 | 61.56 |
| 1 Month | 5,365 | 344,614 | 64.23 |
| 6 Month | 2,903 | 217,220 | 74.83 |
Parmax Pharma Result Highlights
Parmax Pharma Synopsis
BSE-Medical-Diversified
Parmax Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 15.42 Cr. and Equity Capital is Rs. 4.45 Cr. for the Year ended 31/03/2023. Parmax Pharma Ltd. is a Public Limited Listed company incorporated on 02/11/1994 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ1994PLC023504 and registration number is 023504.| Market Cap | 12 |
| Sales | 13 |
| Shares in Float | 0.26 |
| No of funds | |
| Yield |
| Book Value | 2.41 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | 76 |
| Alpha | -0.08 |
| Beta | 0.88 |
Parmax Pharma
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
|---|---|---|---|---|
| Promoters | 30.83% | 30.8% | 30.8% | 30.8% |
| Individual Investors | 65.34% | 65.43% | 65.43% | 65.42% |
| Others | 3.83% | 3.77% | 3.77% | 3.78% |
Parmax Pharma Management
| Name | Designation |
|---|---|
| Dr. Umang Alkesh Gosalia | Managing Director |
| Ms. Ami R Shah | Independent Director |
| Mr. Nikhil S Uchat | Independent Director |
Parmax Pharma Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Parmax Pharma Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-02-14 | Quarterly Results | |
| 2023-11-10 | Quarterly Results | |
| 2023-08-14 | Quarterly Results | |
| 2023-05-30 | Audited Results | |
| 2023-02-11 | Quarterly Results |
Parmax Pharma FAQs
What is Share Price of Parmax Pharma ?
Parmax Pharma share price is ₹31 As on 15 May, 2024 | 07:07
What is the Market Cap of Parmax Pharma ?
The Market Cap of Parmax Pharma is ₹11.9 Cr As on 15 May, 2024 | 07:07
What is the P/E ratio of Parmax Pharma ?
The P/E ratio of Parmax Pharma is -2.9 As on 15 May, 2024 | 07:07
What is the PB ratio of Parmax Pharma ?
The PB ratio of Parmax Pharma is 1.8 As on 15 May, 2024 | 07:07